Boston-based Brit. Curiosity driven, amazed by science. Experienced manager, oncology, pharma R&D, data science. VP Scientific Discovery @TempusLabs
Boston, MA
Joined December 2013
- Tweets544
- Following109
- Followers436
- Likes456
Are you a skilled #datascientist, passionate about advancing #healthcare and #drugdevelopment. We have a unique opportunity @TempusAI to drive an exciting new endeavor in #precisionmedicine boards.greenhouse.io/tempus/… #computationalbiology #machinelearning #realworlddata
I'm really exited to be expanding our group @TempusAI. We are looking for an experienced #realworlddata scientist to take a leading role applying our vast #multimodal datasets to drive new #drugdevelopment with our #pharma partners boards.greenhouse.io/tempus/… #RWE #biostatistics
Fancy hearing about how we used #realworlddata to study the potential and practicality of #transcriptomics to stratify #smallcell #lungcancer #prognosis - I'm excited to be talking @bioitworld tomorrow about this @TempusLabs and @AstraZeneca collaboration
In healthcare "we try to solve problems by building faster and more expensive Ferraris when what we really need are better roads. As a result, our sports cars end up stuck in the mud". Eye opening! lnkd.in/e_vFiaFP
I love finding new ways for the @TempusLabs platform to help new therapies emerge and reach patients - super excited to work with @pfizer tempus.com/news/tempus-annou…
Brilliant to see the start of this clinical journey between @TempusLabs and @AstraZeneca to bring opportunities for new #therapy to patients with #smallcell #lungcancer tempus.com/news/tempus-annou…
The team continues to grow, and we have another opening @TempusLabs #boston for a talented #computationalbiology expert to help us transform #drugdiscovery #drugdevelopment with #genomics #bigdata tempus.com/about-us/careers/…
#computationalbiology opportunities are still available to join this unique team in #Boston or #Chicago & transform #immunooncology drug R&D with the world’s largest #realworld collection of patient #clinical, #omics and #imaging data
Passionate about bringing #bigdata to #precisionmedicine and #cancer #drugdevelopment - there's a unique chance for talented individuals in #computationalbiology and #immunooncology to join us @TempusLabs .
tempus.com/about-us/careers/…
Still time to apply for this unique #job opportunity bringing transformational #realworlddata to world leading #pharma R&D....
Passionate about bringing #bigdata to #precisionmedicine and #cancer #drugdevelopment - there's a unique chance for talented individuals in #computationalbiology and #immunooncology to join us @TempusLabs .
tempus.com/about-us/careers/…
Passionate about bringing #bigdata to #precisionmedicine and #cancer #drugdevelopment - there's a unique chance for talented individuals in #computationalbiology and #immunooncology to join us @TempusLabs .
tempus.com/about-us/careers/…
Proud to be bringing the unique innovation of AstraZeneca ‘s portfolio together with the #realworld #datascience and #clinicalnetwork at Tempus Labs, Inc. to benefit patients with #smallcell #lungcancer lnkd.in/e4q25Ji6
#EarlyDetection, #prevention, and #objective and #equal care for all - strong pillars of a strategy to reduce the #cancer death rate by at least 50 percent thehill-com.cdn.ampproject.o…
I'm delighted to have had the opportunity to author this article - the first in what I hope will be a series sharing our experience in #biomarker validation [#oncology #drugdiscovery #diagnostics #genomics]:
The emergence of cancer #immunotherapies has brought a new level of complexity to the biomarker paradigm. Our VP of scientific discovery @DrySci shares insights on designing validation workflows to increase predictive biomarkers’ probability of success: tempus.co/3K2Brhw
Jonathan Dry retweeted
The emergence of cancer #immunotherapies has brought a new level of complexity to the biomarker paradigm. Our VP of scientific discovery @DrySci shares insights on designing validation workflows to increase predictive biomarkers’ probability of success: tempus.co/3K2Brhw
Jonathan Dry retweeted
.@useless_ulysses @elipapa @KrishnaCBulusu @michaelughetto @dpolychr2 @lostinromsey @drysci @M_Pfiver develop a recommender system ranking genes based on trade-offs between diverse types of evidence linking them to potential mechanisms of EGFRi resistance
go.nature.com/37vJvJ2
After several years and the dedication of an amazing team, I am so excited to see the first published results from the knowledge graph initiative I started at AZ. Incredible work all!
.@useless_ulysses @elipapa @KrishnaCBulusu @michaelughetto @dpolychr2 @lostinromsey @drysci @M_Pfiver develop a recommender system ranking genes based on trade-offs between diverse types of evidence linking them to potential mechanisms of EGFRi resistance
nature.com/articles/s41467-0…
Jonathan Dry retweeted
.@useless_ulysses @elipapa @KrishnaCBulusu @michaelughetto @dpolychr2 @lostinromsey @drysci @M_Pfiver develop a recommender system ranking genes based on trade-offs between diverse types of evidence linking them to potential mechanisms of EGFRi resistance
nature.com/articles/s41467-0…
This exciting team continues to build, and we're welcoming applications from talented experts in #oncology / #drugdevelopment #computationalbiology , #realworldevidence and #bioinformatics lnkd.in/gvGsE7hE
